Skip to main content

Proteome Sciences Settles with Sanofi-Aventis for $15M

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – UK proteomics services provider and reagents firm Proteome Sciences today said they have received €11 million ($15 million) from Sanofi-Aventis Deutschland to settle a claim alleging breach of certain warranties.

Proteome Sciences also announced that its revenues for the first half of 2010 more than doubled compared to a year ago while its net loss narrowed by 10 percent.

Sanofi-Aventis paid Proteome Sciences the €11 million on Wednesday and settled a court claim that Proteome Sciences had filed against the drug maker in connection to a sales and transfer agreement concerning a share and limited partnership interest in Xzillion Proteomics.

Proteome Sciences acquired Xzillion, a proteomics service provider, from Sanofi-Aventis in 2002.

The UK firm provided no further details about the settlement. In its half-year earnings report, R.S. Harris, chairman of the company, said that the €11 million provides it with further financial resources which will allow management "to focus its full attention on the commercial exploitation of the biomarker IP and biomarker services activities."

The company said that for the first half of 2010 ended June 30, revenues rose to £216,366 ($340,925), up 140 percent from £90,321 ($142,341) a year ago. Net loss for the six months was trimmed to £2,162,203, or 1.60p per share, from £2,395,076, or 1.80p per share.

SG&A costs for H1 2010 was £2.3 million, down from £2.4 million a year ago.

Proteome Sciences reported £5,457,414 in cash and cash equivalents as of June 30.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.